{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:06:16Z","timestamp":1789553176594,"version":"build-2803163510"},"reference-count":84,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background: Early broad-spectrum empirical therapy is life-saving in critical illness, but its unnecessary continuation drives resistance, toxicity, and cost; antibiotic de-escalation is the principal stewardship strategy for resolving this tension, yet its evidence base is fragmented and its practice inconsistent. This scoping review mapped the evidence on the definitions, timing, eligibility, implementation, safety, and clinical, microbiological, and resistance outcomes of de-escalating cephalosporins, carbapenems, colistin, and tigecycline in critically ill adults with suspected or confirmed Gram-negative infection. It translated this into a framework for a tertiary-care intensive care unit (ICU). Methods: We conducted a focused scoping review informed by JBI methodological guidance and reported according to PRISMA-ScR. The Web of Science Core Collection was searched for English-language publications from 1 January 2016 to 4 August 2026. Following deduplication, two reviewers independently screened titles and abstracts, and subsequently assessed potentially eligible full texts. Disagreements were resolved through discussion or consultation with a third reviewer. The review was designed to map the characteristics and range of the identified evidence rather than to provide an exhaustive systematic assessment or quantitative synthesis of intervention effects. (PROSPERO CRD420261478424). Results: We included 51 publications (35 empirical studies; 16 reviews, editorials, or consensus statements), with the empirical evidence being predominantly observational, including a single randomized trial. The definitions were heterogeneous, and the spectrum-ranking systems were non-uniform; reassessment typically occurred at 48\u201372 h. The reported de-escalation proportions ranged from approximately 10% in broadly defined treated populations to 71% in a selected, extractable ICU subgroup. These values were not directly comparable because studies used different definitions, eligibility criteria, time points, and denominators, including all patients treated with antibiotics, empirical-treatment episodes, microbiologically documented infections, and patients considered clinically eligible for de-escalation. Direct comparative studies did not identify a consistent increase in mortality following de-escalation; however, the predominantly observational evidence was vulnerable to confounding by indication, survivor bias, and treatment-selection bias, and did not establish equivalence, non-inferiority, or a survival benefit. Conclusions: De-escalation appears safe but rests on low-certainty, heterogeneous evidence. We propose an evidence-informed framework, a structured 48\u201372 h time-out, an eligible-patient denominator and a minimum monitoring dataset for tertiary ICUs, and identify standardized definitions and resistance-focused trials as research priorities. These components represent an evidence-informed implementation proposal developed by the authors and require prospective local validation.<\/jats:p>","DOI":"10.3390\/antibiotics15090912","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:06:37Z","timestamp":1789549597000},"page":"912","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["De-Escalation of Broad-Spectrum and Last-Resort Antibiotics in Critically Ill Adults with Gram-Negative Infections: A Scoping Review and Evidence-Informed Framework for Tertiary-Care ICUs"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4482-2618","authenticated-orcid":false,"given":"Mihai","family":"Sava","sequence":"first","affiliation":[{"name":"County Clinical Emergency Hospital of Sibiu, 2\u20134 Corneliu Coposu Boulevard, 550245 Sibiu, Romania"},{"name":"Faculty of Medicine, Lucian Blaga University of Sibiu, 2A Lucian Blaga Street, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2381-5577","authenticated-orcid":false,"given":"Ioana Roxana","family":"Codru","sequence":"additional","affiliation":[{"name":"County Clinical Emergency Hospital of Sibiu, 2\u20134 Corneliu Coposu Boulevard, 550245 Sibiu, Romania"},{"name":"Faculty of Medicine, Lucian Blaga University of Sibiu, 2A Lucian Blaga Street, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7739-1685","authenticated-orcid":false,"given":"Alina Simona","family":"Bereanu","sequence":"additional","affiliation":[{"name":"County Clinical Emergency Hospital of Sibiu, 2\u20134 Corneliu Coposu Boulevard, 550245 Sibiu, Romania"},{"name":"Faculty of Medicine, Lucian Blaga University of Sibiu, 2A Lucian Blaga Street, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2217-6755","authenticated-orcid":false,"given":"Anca Maria","family":"Fr\u0103\u021bil\u0103","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lucian Blaga University of Sibiu, 2A Lucian Blaga Street, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6264-064X","authenticated-orcid":false,"given":"Bogdan Ioan","family":"Vintil\u0103","sequence":"additional","affiliation":[{"name":"County Clinical Emergency Hospital of Sibiu, 2\u20134 Corneliu Coposu Boulevard, 550245 Sibiu, Romania"},{"name":"Faculty of Medicine, Lucian Blaga University of Sibiu, 2A Lucian Blaga Street, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cid\/civ1199","article-title":"A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-Escalation in the Intensive Care Unit","volume":"62","author":"Tabah","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0000000000007089","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1007\/s12325-020-01390-2","article-title":"Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence","volume":"37","author":"Lakbar","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Vintila, B.I., Arseniu, A.M., Butuca, A., Sava, M., B\u00eerlu\u021biu, V., Rus, L.L., Axente, D.D., Morgovan, C., and Gligor, F.G. (2023). Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050918"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global Burden of Bacterial Antimicrobial Resistance 1990\u20132021: A Systematic Analysis with Forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref_8","unstructured":"(2026, August 16). Antimicrobial Resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report for 2024. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-eueea-ears-net-annual-epidemiological-report-2024."},{"key":"ref_9","unstructured":"Ecdc Carbapenem-Resistant (2025). Enterobacterales\u2013Third Update, 3 February 2025, ECDC."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sava, M., Vintila, B.I., Bereanu, A.S., Fratila, A.M., and Codru, I.R. (2025). Lessons from Four Years (2021\u20132024) of Klebsiella Pneumoniae Resistance Surveillance Epidemiological Trends in a Romanian Intensive Care Unit. Antibiotics, 14.","DOI":"10.3390\/antibiotics14080825"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Codru, I.R., Vintil\u0103, B.I., Bereanu, A.S., Sava, M., Popa, L.M., and Birlutiu, V. (2025). Antimicrobial Resistance Patterns and Biofilm Analysis via Sonication in Intensive Care Unit Patients at a County Emergency Hospital in Romania. Pharmaceuticals, 18.","DOI":"10.3390\/ph18020161"},{"key":"ref_13","unstructured":"WHO (2026, August 18). Policy Guidance on Integrated Antimicrobial Stewardship Activities. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240025530."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13756-021-00961-4","article-title":"Intensivists\u2019 Beliefs about Rapid Multiplex Molecular Diagnostic Testing and Its Potential Role in Improving Prescribing Decisions and Antimicrobial Stewardship: A Qualitative Study","volume":"10","author":"Pandolfo","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Marin, K.C., Ritiu, S.A., B\u0103loi, A., Barsac, C.R., Sandesc, D., Papurica, M., Rogobete, A.F., Toma, D., Porosnicu, M.T., and Gindac, C. (2025). Rapid Molecular Diagnostics for MDR Nosocomial Infections in ICUs: Integration with Prevention, Stewardship, and Novel Therapies. Diagnostics, 15.","DOI":"10.3390\/diagnostics15233060"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"103864","DOI":"10.1016\/j.eclinm.2026.103864","article-title":"Challenges in Early Detection and Prognostication of Sepsis: New Approaches from the Emergency Department and Intensive Care Unit","volume":"94","author":"Lafon","year":"2026","journal-title":"EClinicalMedicine"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tanzarella, E.S., Cutuli, S.L., Lombardi, G., Cammarota, F., Caroli, A., Franchini, E., Sancho Ferrando, E., Grieco, D.L., Antonelli, M., and De Pascale, G. (2024). Antimicrobial De-Escalation in Critically Ill Patients. Antibiotics, 13.","DOI":"10.3390\/antibiotics13040375"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00134-020-06111-5","article-title":"Antimicrobial De-Escalation in the Critically Ill Patient and Assessment of Clinical Cure: The DIANA Study","volume":"46","author":"Depuydt","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jmii.2022.03.003","article-title":"Use of Antimicrobial Agents in Actively Dying Inpatients after Suspension of Life-Sustaining Treatments: Suggestion for Antimicrobial Stewardship","volume":"55","author":"Kim","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sekandarzad, A., Fl\u00fcgler, A., Rheinboldt, A., Rother, D., F\u00f6rst, G., Rieg, S., Supady, A., Lother, A., Staudacher, D.L., and Wengenmayer, T. (2025). Reduced Antimicrobial Consumption through Enhanced Pneumonia Management in Critically Ill Patients: Outcomes of an Antibiotic Stewardship Program in the Intensive Care Unit. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1549355"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lakbar, I., Delamarre, L., Curtel, F., Duclos, G., Bezulier, K., Gragueb-Chatti, I., Martin-Loeches, I., Forel, J.M., and Leone, M. (2022). Antimicrobial Stewardship during COVID-19 Outbreak: A Retrospective Analysis of Antibiotic Prescriptions in the ICU across COVID-19 Waves. Antibiotics, 11.","DOI":"10.3390\/antibiotics11111517"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yu, J., Liu, Y., Qu, R., Wang, Z., Zhao, Y., Zhao, Y., and Zhou, C. (2023). Evaluation of a Clinical Pharmacist-Led Antimicrobial Stewardship Program in a Neurosurgical Intensive Care Unit: A Pre-and Post-Intervention Cohort Study. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1263618"},{"key":"ref_23","first-page":"E0837","article-title":"Impact of Antibiotic Time-Outs in Multidisciplinary ICU Rounds for Antimicrobial Stewardship Program on Patient Survival: A Controlled Before-and-After Study","volume":"5","author":"Mishima","year":"2023","journal-title":"Crit. Care Explor."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100048","DOI":"10.1016\/j.infpip.2020.100048","article-title":"Antimicrobial Stewardship Program at a Tertiary Care Academic Medical Hospital: Clinical, Microbiological and Economic Impact. A 5-Year Temporary Descriptive Study","volume":"2","author":"Vidal","year":"2020","journal-title":"Infect. Prev. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"ofad382","DOI":"10.1093\/ofid\/ofad382","article-title":"Implementation of a Rapid Multiplex Polymerase Chain Reaction Pneumonia Panel and Subsequent Antibiotic De-Escalation","volume":"10","author":"Miller","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_26","first-page":"1595","article-title":"Evaluation of Carbapenem Antimicrobial Stewardship Program at a Tertiary Care Hospital: A Prospective Interventional Study","volume":"35","author":"Ali","year":"2022","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jgar.2021.01.003","article-title":"Impact of an Antimicrobial Stewardship and Monitoring of Infection Control Bundle in a Surgical Intensive Care Unit of a Tertiary-Care Hospital in India","volume":"24","author":"Panditrao","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Schumann, J., Johanns, U., Ahmad-Nejad, P., Ghebremedhin, B., and Woebker, G. (2021). The Impact of the Filmarray-Based Detection of Microbial Pathogens from Positive Blood Culture Vials on the Time to Optimal Antimicrobial Regimen in Intensive Care Units of the Helios University Clinic Wuppertal, Germany. J. Clin. Med., 10.","DOI":"10.3390\/jcm10245880"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.aucc.2022.12.011","article-title":"Benefits of Pharmacist Intervention in the Critical Care Patients with Infectious Diseases: A Propensity Score Matching Retrospective Cohort Study","volume":"36","author":"Gu","year":"2023","journal-title":"Aust. Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s10096-025-05144-2","article-title":"Antibiotic De-Escalation Patterns and Outcomes in Critically Ill Patients with Suspected Pneumonia as Informed by Bronchoalveolar Lavage Results","volume":"44","author":"Zhu","year":"2025","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bjid.2016.06.006","article-title":"Ventilator-Associated Pneumonia: The Influence of Bacterial Resistance, Prescription Errors, and de-Escalation of Antimicrobial Therapy on Mortality Rates","volume":"20","author":"Cunha","year":"2016","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_32","first-page":"e1220","article-title":"Diagnostic Performance and Impact on Antimicrobial Treatment of a Multiplex Polymerase Chain Reaction in Critically Ill Patients with Pneumonia: A Multicenter Observational Study (The MORICUP-PCR Study: Morocco ICU Pneumonia-PCR Study)","volume":"7","author":"Aissaoui","year":"2025","journal-title":"Crit. Care Explor."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Roper, S., Wingler, M.J.B., and Cretella, D.A. (2023). Antibiotic De-Escalation in Critically Ill Patients with Negative Clinical Cultures. Pharmacy, 11.","DOI":"10.3390\/pharmacy11030104"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-G\u00f3mez, M., Mart\u00ednez-Sagasti, F., Calle-Romero, M., Prieto-Cabrera, A., De La Monta\u00f1a-D\u00edaz, P., D\u00edaz-De la Torre, I., Delgado-Iribarren Garc\u00eda-Campero, A., Domingo-Mar\u00edn, S., S\u00e1nchez-Garc\u00eda, M., and Mart\u00edn-Loeches, I. (2025). RAPID-CARE: Rapid Antibiotic Optimization in the ICU After Implementation of a Pneumonia Multiplex PCR Test\u2014A Real-World Evaluation. Antibiotics, 14.","DOI":"10.3390\/antibiotics14111084"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s44197-023-00124-1","article-title":"Effect of Broad-Spectrum Antibiotic De-Escalation on Critically Ill Patient Outcomes: A Retrospective Cohort Study","volume":"13","author":"Aldardeer","year":"2023","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3855\/jidc.17860","article-title":"Predictors of Treatment Failure Following Early Antibiotic Discontinuation in Culture-Negative, Ventilator-Associated Pneumonia: An Observational Study","volume":"18","author":"Le","year":"2024","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Arulappen, A.L., Khan, A.H., Danial, M., Hasan, S.S., Chow, T.S., Ahmed, N.J., and Long, C.M. (2025). Baseline Predictors of Antibiotics De-Escalation from Empirical Therapies in an Intensive Care Unit: A Five-Year Retrospective Study. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10752-6"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13054-017-1772-4","article-title":"Enhanced Antimicrobial De-Escalation for Pneumonia in Mechanically Ventilated Patients: A Cross-over Study","volume":"21","author":"Trupka","year":"2017","journal-title":"Crit. Care"},{"key":"ref_39","first-page":"581","article-title":"Modification of Initial Empirical Antibiotic Prescription and Its Impact on Patient Outcome: Experience of an Indian Intensive Care Unit","volume":"27","author":"Ghosh","year":"2023","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/ijrc.ijrc_76_21","article-title":"Etiology and Risk Factors for Late Antibiotic De-Escalation and Their Effect on Intensive Care Unit Outcome","volume":"10","author":"Choudhuri","year":"2021","journal-title":"Indian J. Respir. Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13054-025-05528-y","article-title":"Diagnostic Performance of Pneumonia Multiplex PCR in Critically Ill Immunocompromised Patients","volume":"29","author":"Contier","year":"2025","journal-title":"Crit. Care"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Latorre Ibars, R., Carvalho-Brugger, S., Rodr\u00edguez Ib\u00e1\u00f1ez, P., Vallverd\u00fa Vidal, M., Iglesias Moles, S., Miralb\u00e9s Torner, M., Bell\u00e9s Bell\u00e9s, A., Castellano, A., Campi, D., and Caballero, J. (2026). Evaluating the Impact of Filmarray Pneumonia Plus Panel in Therapeutic Decision-Making in Critical Patients with Suspected Respiratory Infection. Antibiotics, 15.","DOI":"10.20944\/preprints202605.0866.v1"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1515\/med-2020-0103","article-title":"Successful De-Escalation Antibiotic Therapy Using Cephamycins for Sepsis Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Bacteremia: A Sequential 25-Case Series","volume":"15","author":"Kuwana","year":"2020","journal-title":"Open Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcrc.2019.06.026","article-title":"Safety of Antimicrobial De-Escalation for Culture-Negative Severe Pneumonia","volume":"54","author":"Younsuck","year":"2019","journal-title":"J. Crit. Care"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4266\/acc.005100","article-title":"Real-World Experience Using Multiplex Polymerase Chain Reaction in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia in South Korea","volume":"41","author":"Yoon","year":"2026","journal-title":"Acute Crit. Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13054-018-2091-0","article-title":"Improved Empirical Antibiotic Treatment of Sepsis after an Educational Intervention: The ABISS-Edusepsis Study","volume":"22","author":"Ferrer","year":"2018","journal-title":"Crit. Care"},{"key":"ref_47","first-page":"6794861","article-title":"Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study","volume":"2016","author":"Salahuddin","year":"2016","journal-title":"Crit. Care Res. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4103\/0366-6999.231529","article-title":"Antibiotics De-Escalation in the Treatment of Ventilator-Associated Pneumonia in Trauma Patients: A Retrospective Study on Propensity Score Matching Method","volume":"131","author":"Li","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.18433\/jpps29737","article-title":"Evaluation of the Benefits of De-Escalation for Patients with Sepsis in the Emergency Intensive Care Unit","volume":"21","author":"Niimura","year":"2018","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40560-019-0391-3","article-title":"The Effect of a Rapid Molecular Blood Test on the Use of Antibiotics for Nosocomial Sepsis: A Randomized Clinical Trial","volume":"7","author":"Rodrigues","year":"2019","journal-title":"J. Intensive Care"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"20503121211040702","DOI":"10.1177\/20503121211040702","article-title":"Time to Blood, Respiratory and Urine Culture Positivity in the Intensive Care Unit: Implications for de-Escalation","volume":"9","author":"Sellers","year":"2021","journal-title":"SAGE Open Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"107908","DOI":"10.1016\/j.ijantimicag.2026.107908","article-title":"Missed Opportunities for Antibiotic De-Escalation among Clinically Stable Adult Patients with Bloodstream Infection: Secondary Analysis of a Prospective, Multicentre Study","volume":"67","author":"Nikolai","year":"2026","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijid.2016.06.002","article-title":"Is De-Escalation of Antimicrobials Effective? A Systematic Review and Meta-Analysis","volume":"49","author":"Ohji","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"dlaf022","DOI":"10.1093\/jacamr\/dlaf022","article-title":"Carbapenem De-Escalation as an Antimicrobial Stewardship Strategy: A Narrative Review","volume":"7","author":"Gardner","year":"2025","journal-title":"JAC. Antimicrob. Resist."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jointm.2022.10.001","article-title":"Antimicrobial Stewardship in the Intensive Care Unit","volume":"3","author":"Ture","year":"2023","journal-title":"J. Intensive Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Giamarellou, H., Galani, L., Karavasilis, T., Ioannidis, K., and Karaiskos, I. (2023). Antimicrobial Stewardship in the Hospital Setting: A Narrative Review. Antibiotics, 12.","DOI":"10.3390\/antibiotics12101557"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Di Bella, S., Beovi\u0107, B., Fabbiani, M., Valentini, M., and Luzzati, R. (2020). Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice. Antibiotics, 9.","DOI":"10.3390\/antibiotics9070398"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00134-019-05871-z","article-title":"Antimicrobial De-Escalation as Part of Antimicrobial Stewardship in Intensive Care: No Simple Answers to Simple Questions\u2014A Viewpoint of Experts","volume":"46","author":"Schouten","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/JPBS.JPBS_311_19","article-title":"A Narrative Review of Antimicrobial Stewardship Interventions within In-Patient Settings and Resultant Patient Outcomes","volume":"12","author":"Shirazi","year":"2020","journal-title":"J. Pharm. Bioallied Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3947\/ic.2020.52.1.19","article-title":"Antimicrobial Therapy and Antimicrobial Stewardship in Sepsis","volume":"52","author":"Seok","year":"2020","journal-title":"Infect. Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12325-020-01558-w","article-title":"Antimicrobial Stewardship in the Intensive Care Unit: The Role of Biomarkers, Pharmacokinetics, and Pharmacodynamics","volume":"38","author":"Moniz","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13613-023-01134-9","article-title":"Antibiotic Stewardship in the ICU: Time to Shift into Overdrive","volume":"13","author":"Mokrani","year":"2023","journal-title":"Ann. Intensive Care"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Matuszak, S.S., Kolodziej, L., Micek, S., and Kollef, M. (2025). Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies. Antibiotics, 14.","DOI":"10.3390\/antibiotics14050467"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13054-025-05653-8","article-title":"Optimal Antibiotic Use in the Intensive Care Unit","volume":"29","author":"Micek","year":"2025","journal-title":"Crit. Care"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00134-016-4566-2","article-title":"Focus on Adequate Antimicrobial Treatment and De-Escalation in the ICU","volume":"42","author":"Benoit","year":"2016","journal-title":"Intensive Care Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s44158-023-00095-6","article-title":"Rationale and Clinical Application of Antimicrobial Stewardship Principles in the Intensive Care Unit: A Multidisciplinary Statement","volume":"3","author":"Cortegiani","year":"2023","journal-title":"J. Anesth. Analg. Crit. Care"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","article-title":"De-Escalation versus Continuation of Empirical Antimicrobial Treatment in Severe Sepsis: A Multicenter Non-Blinded Randomized Noninferiority Trial","volume":"40","author":"Leone","year":"2014","journal-title":"Intensive Care Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9776","DOI":"10.1038\/s41598-024-60041-6","article-title":"Simplified Spectrum Score (S3) App for Pathogen-Agnostic Antimicrobial Drug Spectrum Ranking to Assess for Antimicrobial de-Escalation Events","volume":"14","author":"Schrenzel","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Stoian, M., Azamfirei, L., Andone, A., V\u0103sie\u0219iu, A.M., St\u00eengaciu, A., Hu\u021banu, A., B\u00e2ndil\u0103, S.R., Dobru, D., Manea, A., and Stoian, A. (2025). Incidence and Risk Factors of Secondary Infections in Critically Ill SARS-CoV-2 Patients: A Retrospective Study in an Intensive Care Unit. Biomedicines, 13.","DOI":"10.3390\/biomedicines13061333"},{"key":"ref_70","first-page":"CD007934","article-title":"De-Escalation of Antimicrobial Treatment for Adults with Sepsis, Severe Sepsis or Septic Shock","volume":"2013","author":"Silva","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"649.e1","DOI":"10.1016\/j.cmi.2015.03.013","article-title":"Elaboration of a Consensual Definition of De-Escalation Allowing a Ranking of \u03b2-Lactams","volume":"21","author":"Weiss","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00134-019-05866-w","article-title":"Antimicrobial De-Escalation in Critically Ill Patients: A Position Statement from a Task Force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)","volume":"46","author":"Tabah","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Bereanu, A.S., Vintil\u0103, B.I., Oprinca-Muja, L.A., Bereanu, R., Codru, I.R., B\u0103dil\u0103, R.M., Neam\u021bu, S.I., Mohor, C.I., Prodan, L.C., and Sava, M. (2026). Prevalence and Multidrug Resistance of WHO-Priority Bacterial Pathogens in a Romanian Intensive Care Unit. J. Clin. Med., 15.","DOI":"10.3390\/jcm15072799"},{"key":"ref_74","unstructured":"(2026, August 19). AWaRe Classification of Antibiotics for Evaluation and Monitoring of Use. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.04."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1017\/ice.2017.94","article-title":"Development and Application of an Antibiotic Spectrum Index for Benchmarking Antibiotic Selection Patterns Across Hospitals","volume":"38","author":"Gerber","year":"2017","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"E4507","DOI":"10.1093\/cid\/ciaa932","article-title":"Development of an Electronic Definition for De-Escalation of Antibiotics in Hospitalized Patients","volume":"73","author":"Moehring","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Madaras-Kelly, K., Jones, M., Remington, R., Caplinger, C., Huttner, B., and Samore, M. (2015). Description and Validation of a Spectrum Score Method to Measure Antimicrobial De-Escalation in Healthcare Associated Pneumonia from Electronic Medical Records Data. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-0933-9"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Vintila, B.I., Arseniu, A.M., Morgovan, C., Butuca, A., Sava, M., B\u00eerlu\u021biu, V., Rus, L.L., Ghibu, S., Bereanu, A.S., and Roxana Codru, I. (2023). A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides Difficile Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care Units. Pharmaceuticals, 16.","DOI":"10.3390\/ph16111585"},{"key":"ref_79","unstructured":"World Health Organization, Food and Agriculture Organization of the United Nations, and World Organization for Animal Health (2022). Strategic Framework for Collaboration on Antimicrobial Resistance\u2014Together for One Health, World Health Organization."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Sava, M., Codru, I.R., Bereanu, A.S., Stoia, O., and Vintila, B.I. (2025). Resistance Dynamics in a Romanian Critical Care Unit: Four Years of ESKAPE Pathogen Surveillance. Medicina, 61.","DOI":"10.3390\/medicina61122114"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Stoian, M., Azamfirei, L., St\u00e2ngaciu, A.C., Manea, S., Onisor, D., Manea, A., Cora, A., Danilesco, A., Man, A., and Stoian, A. (2026). Six Years of Acinetobacter Species in Critical Care: Carbapenem Resistance and Non-Susceptibility, Clinical Outcomes, and Lessons for Stewardship. Antibiotics, 15.","DOI":"10.3390\/antibiotics15030267"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6286424","DOI":"10.1155\/ijm\/6286424","article-title":"Risk Factors and Antibiotic Utilization Patterns in Multidrug-Resistant Surgical Infections: A Retrospective Study from a Romanian Tertiary-Care Center","volume":"2026","author":"Ambrosie","year":"2026","journal-title":"Int. J. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial Therapeutic Drug Monitoring in Critically Ill Adult Patients: A Position Paper","volume":"46","author":"Alffenaar","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/9\/912\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:34:04Z","timestamp":1789551244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/9\/912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":84,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["antibiotics15090912"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15090912","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}